# to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers

> **NCT01926548** · PHASE1 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CJ Imatinib mesylate tablet
- **DRUG:** Gleevec film-coated tablet 2 x 100mg

## Key facts

- **NCT ID:** NCT01926548
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-03
- **Final completion:** 2012-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01926548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01926548, "to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01926548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*